RURIOCTOCOG ALFA PEGOL for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where RURIOCTOCOG ALFA PEGOL was used for Factor viii deficiency.
Most Reported Side Effects for RURIOCTOCOG ALFA PEGOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemarthrosis | 18 | 24.7% | 0 | 3 |
| Haemorrhage | 12 | 16.4% | 0 | 1 |
| Arthralgia | 10 | 13.7% | 0 | 1 |
| Fall | 8 | 11.0% | 0 | 3 |
| Product use issue | 7 | 9.6% | 0 | 0 |
| Contusion | 6 | 8.2% | 0 | 1 |
| Haematoma | 5 | 6.9% | 0 | 1 |
| Inappropriate schedule of product administration | 5 | 6.9% | 0 | 2 |
| Product dose omission issue | 5 | 6.9% | 0 | 0 |
Other Indications for RURIOCTOCOG ALFA PEGOL
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)